Related Experiment Video
Updated: Jul 2, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Insulin Resistance: The Increased Risk of Cancers
1Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5 Str., 02-004 Warsaw, Poland.
Insulin resistance and hyperinsulinemia are linked to metabolic impairments, increasing risks for obesity, type 2 diabetes, and cancer. These conditions worsen cancer outcomes and treatment effectiveness.
Area of Science:
- Metabolic disorders
- Oncology
- Endocrinology
Background:
- Insulin resistance, or impaired insulin sensitivity, is a condition where cells respond poorly to insulin.
- This leads to elevated insulin levels (hyperinsulinemia), contributing to metabolic impairments seen in obesity and type 2 diabetes.
- Hyperinsulinemia is increasingly recognized as a significant factor in obesity, type 2 diabetes, and cancer development.
Purpose of the Study:
- To explore the pathogenic mechanisms linking insulin resistance to cancer.
- To discuss the impact of metabolic disorders on cancer initiation, progression, and treatment outcomes.
Main Methods:
- Literature review and synthesis of existing research on insulin resistance, metabolic disorders, and cancer.
- Analysis of epidemiological data and clinical observations.
Main Results:
- Insulin resistance and hyperinsulinemia are associated with increased risks of cancer initiation, progression, and metastasis.
- Metabolic disorders in cancer patients correlate with poorer treatment outcomes, including higher recurrence rates and reduced survival.
- Obesity and type 2 diabetes independently and additively increase cancer risk.
Conclusions:
- Insulin resistance and associated metabolic dysregulation are critical factors in cancer development and progression.
- Understanding these mechanisms is vital for improving cancer prevention and treatment strategies.
- Addressing metabolic health may offer novel therapeutic avenues in oncology.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications

